Crystal structure of SPSB2 in complex with a rational designed RGD-containing cyclic peptide inhibitor of SPSB2-iNOS interaction
Crystal structure of SPSB2 in complex with a rational designed RGD-containing cyclic peptide inhibitor of SPSB2-iNOS interaction
复制标题
SPSB2与合理设计的含有RGD的SPSB2-iNOS相互作用环肽抑制剂复合物的晶体结构
DOI:
10.1016/j.bbrc.2017.05.122
复制
发表时间:
2017
影响因子:
3.1
通讯作者:
Kuang Zhihe
中科院分区:
文献类型:
--
作者:
You Tingting;Wang Yuhui;Li Kefa;Zhang Danting;Wei Huan;Luo Yanhong;Li Hua;Lu Yongzhi;Su Xunchen;Kuang Zhihe
SPRY domain-containing SOCS box protein 2 (SPSB2) is a negative regulator of inducible nitric oxide synthase (iNOS) that modulates the lifetime of iNOS and thus the levels of nitric oxide (NO) production. Inhibitors that can disrupt the endogenous SPSB2-iNOS interaction and augment NO production have potential as novel antimicrobial and anticancer drugs. In this study, we have designed a cyclic peptide (cR8), containing an RGD motif and the SPSB2 binding motif (DINNNV). ITC and chemical shift perturbation showed that cR8 binds to the iNOS binding site on SPSB2 with a Kdof 671 nM, and saturation transfer difference NMR showed that cR8 binds to αvβ3integrin-expressing cells. Moreover, we determined the crystal structure of SPSB2 in complex with cR8, at a resolution of 1.34 Å. cR8 forms extensive hydrogen bonding with SPSB2 residues, but loss of an intramolecular hydrogen bond that is present in SPSB2-bound iNOS peptide may destabilize the bound conformation of cR8 and lead to a gentle reduction in SPSB2 binding affinity. These results serve as a useful basis for designing site-directed SPSB2 inhibitors in the future.